BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7976630)

  • 1. Treatment of vasogenic brain edema with arginine vasopressin receptor antagonist--an experimental study.
    Nagao S; Kagawa M; Bemana I; Kuniyoshi T; Ogawa T; Honma Y; Kuyama H
    Acta Neurochir Suppl (Wien); 1994; 60():502-4. PubMed ID: 7976630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study.
    Kagawa M; Nagao S; Bemana I
    J Neurotrauma; 1996 May; 13(5):273-9. PubMed ID: 8797177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats.
    Bemana I; Nagao S
    Neurosurgery; 1999 Jan; 44(1):148-54; discussion 154-5. PubMed ID: 9894975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OPC-21268, an orally effective, nonpeptide arginine vasopressin V1 receptor antagonist reduces vasogenic brain edema.
    Bemana I; Takahashi E; Nakamura T; Kuyama H; Nagao S
    Acta Neurochir Suppl; 1997; 70():194-7. PubMed ID: 9416320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of arginine vasopressin receptor antagonist on the rat cold-injured brain].
    Kagawa M; Nagao S
    No Shinkei Geka; 1993 Dec; 21(12):1103-7. PubMed ID: 8259220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats.
    Rosenberg GA; Scremin O; Estrada E; Kyner WT
    Stroke; 1992 Dec; 23(12):1767-73; discussion 1773-4. PubMed ID: 1448828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with nicardipine, phenobarbital, and methylprednisolone ameliorates vasogenic brain edema.
    Lin SZ; Chiou TL; Chiang YH; Song WS
    Acta Neurochir Suppl (Wien); 1994; 60():528-30. PubMed ID: 7976639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of traumatic brain edema by multiple doses of mannitol.
    von Berenberg P; Unterberg A; Schneider GH; Lanksch WR
    Acta Neurochir Suppl (Wien); 1994; 60():531-3. PubMed ID: 7976640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdural cortical stabbing facilitates the drainage of edema fluid out of cold-injured brain.
    Chiou TL; Chiang YH; Song WS; Lin SS
    Acta Neurochir Suppl (Wien); 1994; 60():459-61. PubMed ID: 7976620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannitol, intracranial pressure, and vasogenic edema.
    Hartwell RC; Sutton LN
    Neurosurgery; 1993 Mar; 32(3):444-50; discussion 450. PubMed ID: 8455770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
    Zeynalov E; Jones SM; Seo JW; Snell LD; Elliott JP
    PLoS One; 2015; 10(8):e0136121. PubMed ID: 26275173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide (ANP) attenuates brain oedema accompanying experimental subarachnoid haemorrhage.
    Dóczi TP; Joó F; Balás I
    Acta Neurochir (Wien); 1995; 132(1-3):87-91. PubMed ID: 7754864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute isotonic saline administration on serum osmolality, serum electrolytes, brain water content and intracranial pressure.
    James HE; Schneider S
    Acta Neurochir Suppl (Wien); 1993; 57():89-93. PubMed ID: 8421958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of vasopressin v1a receptors after traumatic brain injury.
    Szmydynger-Chodobska J; Chung I; Koźniewska E; Tran B; Harrington FJ; Duncan JA; Chodobski A
    J Neurotrauma; 2004 Aug; 21(8):1090-102. PubMed ID: 15319008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.
    Liu X; Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
    Neurocrit Care; 2010 Feb; 12(1):124-31. PubMed ID: 19806476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
    Kleindienst A; Dunbar JG; Glisson R; Marmarou A
    Acta Neurochir (Wien); 2013 Jan; 155(1):151-64. PubMed ID: 23188468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats.
    Schulz J; Plesnila N; Eriskat J; Stoffel M; Pruneau D; Baethmann A
    Acta Neurochir Suppl; 2000; 76():137-9. PubMed ID: 11449993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihistaminics on experimental brain edema.
    Schilling L; Wahl M
    Acta Neurochir Suppl (Wien); 1994; 60():79-82. PubMed ID: 7976662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 21-Aminosteroid U-74389F reduces vasogenic brain edema.
    Schneider GH; Unterberg A; Lanksch WR
    Acta Neurochir Suppl (Wien); 1994; 60():516-8. PubMed ID: 7976635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
    Vakili A; Kataoka H; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.